Amgen, Inc. (AMGN) Tops Q2 EPS by 29c

July 26, 2012 4:06 PM EDT Send to a Friend
Get Alerts AMGN Hot Sheet
Trade AMGN Now!
Amgen, Inc. (NASDAQ: AMGN) reported Q2 EPS of $1.83, $0.29 better than the analyst estimate of $1.54. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.08 billion.

Amgen, Inc. sees FY2012 EPS of $6.20-$6.35, versus prior guidance of $5.90-$6.15 and the consensus of $6.15. Amgen, Inc. sees FY2012 revenue of (n/a).

For earnings history and earnings-related data on Amgen, Inc. (AMGN) click here.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment